ArticleRevista medica del Instituto Mexicano del Seguro Social2024
Cancer epidemiology in pathology of a hospital in eastern Mexico
Article in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [2018-2024 Cancer Trends in Pathology of a Hospital in Eastern Mexico].Revista medica del Instituto Mexicano del Seguro Social · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cancer is one of the leading causes of death in the world. In Mexico, its incidence has increased, and differences have been reported regarding the regions of the country. Objective: To study the epidemiology of malignant neoplasms diagnosed in the Pathology department of a hospital in eastern Mexico. Material and methods: We studied the different cancer types diagnosed in Pathology of the Hospital Centro Médico Nacional "General de División Manuel Ávila Camacho" during 2019. Results: In the region, women were more affected than men, presenting more cases. In the total population, we found a high proportion of breast and skin cancers and a decreased proportion of lung cancer, both compared with Mexico and the world (2020). In men, we found a decreased prostate cancer proportion compared to Mexico. We also observed a high proportion of skin cancer (higher than Mexico and the world) and a high percentage of higher digestive system cases, compared to Mexico. For women, we found a high percentage of breast and skin cancers compared to Mexico and the world; and a decreased percentage of cervical cancer when compared to data from Mexico. Conclusions: Knowing cancer epidemiology in the regions of Mexico can help implement cancer control, screening activities and to provide a timely treatment.
Indexed as
Identifiers
39509179PMC12133223What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.